Translation News and Research

RSS

IRB Barcelona team receives ERC grant to develop new drugs against fibrosis

The team led by Manuel Serrano, ICREA researcher and Head of the Cellular Plasticity and Disease Lab at IRB Barcelona, has been awarded the Proof of Concept grant by the European Research Council.

31 Jul 2020

Portable, injectable clotting agent reduces blood loss by 97% in mice models

When it comes to traumatic injuries, it's a race against time. A person with major hemorrhage can die from blood loss within minutes, so staunching the wound and getting them to a hospital as fast as possible is critical.

31 Jul 2020

Human cerebellum has almost 80% of the cerebral cortex’s surface area

When we say someone has a quick mind, it may be in part thanks to our expanded cerebellum that distinguishes human brains from those of macaque monkeys, for example.

31 Jul 2020

UVA now supports engineering-to-medicine faculty fellowships

The University of Virginia's Center for Engineering in Medicine now supports faculty fellowships that embed engineering faculty members within the UVA School of Medicine.

31 Jul 2020

15 young scientists receive Damon Runyon Fellowship Award to pursue cancer research

Grants totaling nearly $3.5 million give early career investigators independence to pursue brave and bold cancer research.

31 Jul 2020

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Harbour BioMed, a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.

31 Jul 2020

Compounds demonstrate promising activity against tuberculosis

Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases - tuberculosis (TB).

30 Jul 2020

Two-step targeting strategy can increase clinical translation of nanoparticle-based therapies

Therapy-loaded nanoparticles may be directed to the brain by functionalization with ligands targeting BBB-associated proteins.

27 Jul 2020

Plant-based diet with small amounts of meat and dairy can still lower blood pressure

Consuming a plant-based diet can lower blood pressure even if small amounts of meat and dairy are consumed too, according to new research from the University of Warwick.

25 Jul 2020

Technology divide between senior ‘haves’ and ‘have-nots’ roils pandemic response

Family gatherings on Zoom and FaceTime. Online orders from grocery stores and pharmacies. Telehealth appointments with physicians.

24 Jul 2020

Research could lead to more efficient cellular immunotherapies for advanced cancers

Adoptive cell transfer immunotherapy is one of the most promising new treatments for people with hard-to-treat cancers.

23 Jul 2020

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

The cover for issue 29 of Oncotarget features, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model," by Lara, et al. which reported that adaptor proteins such as growth factor receptor-bound protein-2 play important roles in cancer cell signaling.

23 Jul 2020

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

Wyss Institute's tough gel adhesive technology licensed to Amend Surgical

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.

21 Jul 2020

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.

21 Jul 2020

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK’s innovation agency.

From Fluidic Sciences and Sphere Bio 20 Jul 2020

SARS-CoV-2 protein effectively shuts down production of proteins in the host, study shows

A detailed study of a SARS-Cov-2 protein, Nsp1, with a central role in weakening the host anti-viral immune response shows that it effectively shuts down production ofproteins in the host.

17 Jul 2020

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Researchers from the Moscow Institute of Physics and Technology and their colleagues from Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry and Prokhorov General Physics Institute of the Russian Academy of Sciences have developed a breakthrough technology to resolve a key problem that has prevented the introduction of novel drugs into clinical practice for decades.

17 Jul 2020

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.

15 Jul 2020

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Now, a new study describes how compounds that restore the normal transcriptional conditions following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be used to reduce viral load without neutralizing the virus entry into the host cell.

15 Jul 2020

Translation News and Research

IRB Barcelona team receives ERC grant to develop new drugs against fibrosis

Portable, injectable clotting agent reduces blood loss by 97% in mice models

Human cerebellum has almost 80% of the cerebral cortex’s surface area

UVA now supports engineering-to-medicine faculty fellowships

15 young scientists receive Damon Runyon Fellowship Award to pursue cancer research

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Compounds demonstrate promising activity against tuberculosis

Two-step targeting strategy can increase clinical translation of nanoparticle-based therapies

Plant-based diet with small amounts of meat and dairy can still lower blood pressure

Technology divide between senior ‘haves’ and ‘have-nots’ roils pandemic response

Research could lead to more efficient cellular immunotherapies for advanced cancers

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Wyss Institute's tough gel adhesive technology licensed to Amend Surgical

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

SARS-CoV-2 protein effectively shuts down production of proteins in the host, study shows

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News